Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus

Ankit Gupta; Herbert F. Jelinek; Hayder Al-Aubaidy

doi:10.1016/j.dsx.2016.09.003

Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus

Ankit Gupta, Herbert F. Jelinek, Hayder Al-Aubaidy

Biomedical Engineering & Biotechnology

University of Tasmania

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Abstract

This study summarizes major work which investigated the roles of glucagon like peptide-1 (GLP-1) and its receptor (GLP-1R); the use of GLP-1-R agonists and dipeptidyl peptidase 4 inhibitor in the management of type 2 diabetes mellitus. It focuses on the recent therapeutic development which has occurred in this field, and also discusses the potential treatments which can be discovered and implemented in the near future to design an effective therapy for type 2 diabetes mellitus.

Original language	British English
Pages (from-to)	225-230
Number of pages	6
Journal	Diabetes and Metabolic Syndrome: Clinical Research and Reviews
Volume	11
Issue number	3
DOIs	https://doi.org/10.1016/j.dsx.2016.09.003
State	Published - Jul 2017

Keywords

Dipeptidyl peptidase inhibitors
Glucagon like peptide-1
Type 2 diabetes mellitus

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.dsx.2016.09.003

Cite this

@article{41518635ddfb4c549784d3f3556e12dd,

title = "Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus",

abstract = "This study summarizes major work which investigated the roles of glucagon like peptide-1 (GLP-1) and its receptor (GLP-1R); the use of GLP-1-R agonists and dipeptidyl peptidase 4 inhibitor in the management of type 2 diabetes mellitus. It focuses on the recent therapeutic development which has occurred in this field, and also discusses the potential treatments which can be discovered and implemented in the near future to design an effective therapy for type 2 diabetes mellitus.",

keywords = "Dipeptidyl peptidase inhibitors, Glucagon like peptide-1, Type 2 diabetes mellitus",

author = "Ankit Gupta and Jelinek, {Herbert F.} and Hayder Al-Aubaidy",

note = "Publisher Copyright: {\textcopyright} 2016 Diabetes India",

year = "2017",

month = jul,

doi = "10.1016/j.dsx.2016.09.003",

language = "British English",

volume = "11",

pages = "225--230",

journal = "Diabetes and Metabolic Syndrome: Clinical Research and Reviews",

issn = "1871-4021",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - Glucagon like peptide-1 and its receptor agonists

T2 - Their roles in management of Type 2 diabetes mellitus

AU - Gupta, Ankit

AU - Jelinek, Herbert F.

AU - Al-Aubaidy, Hayder

PY - 2017/7

Y1 - 2017/7

N2 - This study summarizes major work which investigated the roles of glucagon like peptide-1 (GLP-1) and its receptor (GLP-1R); the use of GLP-1-R agonists and dipeptidyl peptidase 4 inhibitor in the management of type 2 diabetes mellitus. It focuses on the recent therapeutic development which has occurred in this field, and also discusses the potential treatments which can be discovered and implemented in the near future to design an effective therapy for type 2 diabetes mellitus.

AB - This study summarizes major work which investigated the roles of glucagon like peptide-1 (GLP-1) and its receptor (GLP-1R); the use of GLP-1-R agonists and dipeptidyl peptidase 4 inhibitor in the management of type 2 diabetes mellitus. It focuses on the recent therapeutic development which has occurred in this field, and also discusses the potential treatments which can be discovered and implemented in the near future to design an effective therapy for type 2 diabetes mellitus.

KW - Dipeptidyl peptidase inhibitors

KW - Glucagon like peptide-1

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=85007017847&partnerID=8YFLogxK

U2 - 10.1016/j.dsx.2016.09.003

DO - 10.1016/j.dsx.2016.09.003

M3 - Review article

C2 - 27884496

AN - SCOPUS:85007017847

SN - 1871-4021

VL - 11

SP - 225

EP - 230

JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

JF - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

IS - 3

ER -

Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this